Results 11 to 20 of about 700,500 (193)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? [PDF]

Human Vaccines & Immunotherapeutics, 2021
Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous ...
Om Prakash Choudhary, Priyanka, Jivan Q. Ahmed, Teroj A. Mohammed, Indraj Singh, Alfonso J. Rodriguez-Morales   +5 more
doaj   +6 more sources

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials

Viruses, 2010
Currently, there are more than 30 million people infected with HIV-1 and thousands more are infected each day. Vaccination is the single most effective mechanism for prevention of viral disease, and after more than 25 years of research, one vaccine has ...
Julia L. Hurwitz, Patricia Flynn, Pamela Freiden, Nanna Howlett, Timothy D. Lockey, Kristen Branum, Karen S. Slobod, Bart G. Jones, Robert Sealy, Scott A. Brown, Sherri L. Surman   +10 more
doaj   +4 more sources

Heterologous Prime Boost COVID 19 Vaccination [PDF]

Infectious Diseases Now, 2022
Heterologous prime boost vaccination is a primary vaccination with different vaccines, most often from different vaccine platforms. It combines the immunological properties of the different vaccines and thereby induces humoral, cellular and, in some cases, mucosal response.
O Launay
exaly   +4 more sources

Antibody Response after Homologous and Heterologous Prime–Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort [PDF]

Vaccines
COVID-19 vaccination strategies, including heterologous prime–boost regimens and additional booster doses, aim to optimize immune responses. However, seroepidemiological studies on immune responses to different COVID-19 vaccine types and schedules remain
Nihad Adnan, Md. Ahsanul Haq, Salma Akter, S. M. Shafiul Alam Sajal, Md. Fokhrul Islam, Taslin Jahan Mou, Mohd. Raeed Jamiruddin, Fatema Tuz Jubyda, Md. Salequl Islam, Jamsheda Ferdous Tuli, Syeda Moriam Liza, Sharif Hossain, Zinia Islam, Sohel Ahmed, Shahad Saif Khandker, Rubel Hossain, Md. Firoz Ahmed, Mohib Ullah Khondoker, Nafisa Azmuda, Md. Anowar Khasru Parvez   +19 more
doaj   +3 more sources

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant [PDF]

Frontiers in Immunology, 2022
With the emergence of novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Variants of Concern (VOCs), vaccination studies that elucidate the efficiency and effectiveness of a vaccination campaign are critical to assess the durability and ...
Natalie Heinen, Corinna Sophie Marheinecke, Clara Bessen, Arturo Blazquez-Navarro, Arturo Blazquez-Navarro, Toralf Roch, Toralf Roch, Ulrik Stervbo, Moritz Anft, Carlos Plaza-Sirvent, Sandra Busse, Mara Klöhn, Jil Schrader, Elena Vidal Blanco, Doris Urlaub, Carsten Watzl, Markus Hoffmann, Stefan Pöhlmann, Matthias Tenbusch, Eike Steinmann, Daniel Todt, Daniel Todt, Carsten Hagenbeck, Gert Zimmer, Gert Zimmer, Wolfgang Ekkehard Schmidt, Daniel Robert Quast, Nina Babel, Nina Babel, Ingo Schmitz, Stephanie Pfänder   +30 more
doaj   +5 more sources

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens. [PDF]

PLoS ONE, 2012
We characterized prime-boost vaccine regimens using heterologous and homologous vector and gene inserts. Heterologous regimens offer a promising approach that focuses the cell-mediated immune response on the insert and away from vector-dominated ...
Silvia Ratto-Kim, Jeffrey R Currier, Josephine H Cox, Jean-Louis Excler, Anais Valencia-Micolta, Doris Thelian, Vicky Lo, Eddy Sayeed, Victoria R Polonis, Patricia L Earl, Bernard Moss, Merlin L Robb, Nelson L Michael, Jerome H Kim, Mary A Marovich   +14 more
doaj   +2 more sources

Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review

Infectious Disease Reports, 2022
Various safe and effective COVID-19 vaccines utilizing different platforms (mRNA, adenovirus vector, inactivated virus-based) are available against SARS-CoV-2 infection.
Ishan Garg, Abu Baker Sheikh, Suman Pal, Rahul Shekhar   +3 more
doaj   +2 more sources

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus [PDF]

Virology Journal, 2020
Background Tembusu virus (TMUV), a newly emerging pathogenic flavivirus, spreads rapidly between ducks, causing massive economic losses in the Chinese duck industry. Vaccination is the most effective method to prevent TMUV.
Yuting Pan, Renyong Jia, Juping Li, Mingshu Wang, Shun Chen, Mafeng Liu, Dekang Zhu, Xinxin Zhao, Ying Wu, Qiao Yang, Zhongqiong Yin, Bo Jing, Juan Huang, Shaqiu Zhang, Lin Zhang, Yunya Liu, Yanlin Yu, Bin Tian, Leichang Pan, Mujeeb Ur Rehman, Anchun Cheng   +20 more
doaj   +5 more sources

Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep [PDF]

Frontiers in Immunology, 2023
Contagious ecthyma (Orf), an acute and highly contagious zoonosis, is prevalent worldwide. Orf is caused by Orf virus (ORFV), which mainly infects sheep/goats and humans. Therefore, effective and safe vaccination strategies for Orf prevention are needed.
Yan Wang, Shihui Sun, Kui Zhao, Le Du, Xinyue Wang, Wenqi He, Feng Gao, Deguang Song, Jiyu Guan   +8 more
doaj   +2 more sources

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs [PDF]

Veterinary Research, 2020
Influenza A viruses evolve rapidly to escape host immunity. In swine, this viral evolution has resulted in the emergence of multiple H1 and H3 influenza A virus (IAV) lineages in the United States (US) pig populations.
Chong Li, Marie R. Culhane, Maxim Cheeran, Lucina Galina Pantoja, Micah L. Jansen, Deborah Amodie, Martha A. Mellencamp, Montserrat Torremorell   +7 more
doaj   +4 more sources